ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements with these filters
Lactose India Ltd intimated a board meeting on 14 November 2026 to approve Q2/H1 unaudited results and allot 15,89,200 equity shares under an NCLT-sanctioned scheme of arrangement. Trading window closure notice is also included.
Lactose (India) fixed November 2, 2026 as record date for the NCLT-approved amalgamation with Vitanosh Ingredients at a 0.7946 share exchange ratio.
Lactose India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Lactose India Ltd has appointed Alpesh A. Lakeshri as the Cost Auditor for the financial year 2026-27.
Lactose (India) Limited concluded its 35th Annual General Meeting, where shareholders approved financial statements, director appointments, remuneration revisions, and related party transactions.
Lactose (India) Limited announced its 35th Annual General Meeting to be held on September 30, 2026, along with relevant book closure and e-voting schedules.
Lactose (India) Limited has filed its 35th Annual Report for the financial year 2025-26 with the stock exchange.
Lactose (India) Limited announced that the Scheme of Amalgamation with Vitanosh Ingredients Private Limited has become effective as of September 05, 2026.
Lactose (India) Limited appointed AMS & CO LLP as Internal Auditor and Alpesh A. Lakeshri as Cost Auditor, each for a 12-month term.
Lactose (India) Limited's board meeting approved various reports, audit appointments, director remuneration, and the convening of the 35th Annual General Meeting.
Lactose (India) Limited received the NCLT Ahmedabad order sanctioning the Scheme of Amalgamation with Vitanosh Ingredients Private Limited. The merger becomes effective in due course.
Lactose (India) Ltd reported revenue from operations of ₹47 Cr (+18.7% YoY) and net profit of ₹2.4 Cr (+60.0% YoY) for Q1 FY27.
Lactose India will hold a board meeting on August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Lactose India Ltd filed its quarterly shareholding pattern as of June 30, 2026. The report details holdings across promoter and public categories.
CRISIL reaffirmed Lactose (India) Limited's long-term rating at 'CRISIL BBB-/Stable'. The rated bank facilities were enhanced to Rs. 90 Crore from Rs. 60 Crore.
Lactose India Ltd's board will meet on 18th June 2026 to consider forfeiting 15,00,000 convertible warrants. This action may impact the company's capital structure and investor sentiment.
Lactose (India) Limited submitted its Annual Secretarial Compliance Report for the financial year 2026. The report confirms adherence to SEBI regulations with no major non-compliances noted.
Lactose (India) Ltd reported revenue from operations of ₹45.8 Cr (+64.7% YoY) and net profit of ₹1.9 Cr (+216.7% YoY) for Q4 FY26.
Lactose India reported total annual income of ₹164.36 Crore for FY26. Net profit stood at ₹6.06 Crore, reflecting sustained growth and operational stability for investors.